NXY-059
CAS No. 168021-79-2
NXY-059( NXY 059 | NXY059 | Disufenton sodium )
Catalog No. M12566 CAS No. 168021-79-2
NXY-059 (Disufenton sodium) is a free radical-trapping agent that demonstrates a considerable neuroprotective effect in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 38 | In Stock |
|
| 5MG | 35 | In Stock |
|
| 10MG | 57 | In Stock |
|
| 25MG | 112 | In Stock |
|
| 50MG | 181 | In Stock |
|
| 100MG | 276 | In Stock |
|
| 200MG | 426 | In Stock |
|
| 500MG | 691 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNXY-059
-
NoteResearch use only, not for human use.
-
Brief DescriptionNXY-059 (Disufenton sodium) is a free radical-trapping agent that demonstrates a considerable neuroprotective effect in vivo.
-
DescriptionNXY-059 (Disufenton sodium) is a free radical-trapping agent that demonstrates a considerable neuroprotective effect in vivo; exhibits a substantial protective effect, lessening the disability caused by an experimentally induced stroke in a primate species, shows significantly decreased neurological impairment in rat model of hemorrhagic stroke.Stroke Phase 3 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsNXY 059 | NXY059 | Disufenton sodium
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaNeurological Disease
-
IndicationStroke
Chemical Information
-
CAS Number168021-79-2
-
Formula Weight381.3329
-
Molecular FormulaC11H13NNa2O7S2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)(C)[N+](=CC1=C(C=C(C=C1)S(=O)(=O)[O-])S(=O)(=O)[O-])[O-].[Na+].[Na+]
-
Chemical Name1,3-Benzenedisulfonic acid, 4-[[(1,1-dimethylethyl)oxidoimino]methyl]-, sodium salt (1:2)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
(R)-3-Hydroxybutanoi...
3-hydroxybutyric acid is involved in the synthesis and degradation of ketone bodies. Like the other ketone bodies (acetoacetate and acetone) levels of beta-hydroxybutyrate are raised in the blood and urine in ketosis. Beta-hydroxybutyrate is a typical partial-degradation product of branched-chain amino acids (primarily valine) released from muscle for hepatic and renal gluconeogenesis.
-
Demethoxycurcumin
Demethoxycurcumin is a potential additive natural product in combination with chemotherapeutic agents in drug-resistant cancers.
-
Bemnifosbuvir
Bemnifosbuvir is a novel phosphoramidate prodrug of 2'-fluoro-2'-C-methylguanosine-5'-monophosphate that has potent in vitro activity against HCV.
Cart
sales@molnova.com